Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology

• ClinicalTrials.gov Identifier: NCT02671669
• Recruitment Status: Completed
• First Posted: February 2, 2016
• Last Update Posted: May 22, 2020
• Sponsor: NYU Langone Health
• Information provided by (Responsible Party): NYU Langone Health

Study Description

Brief Summary:

This is a randomized controlled trial of the feasibility and utility of implementing a smartphone application (MVN) to maintain compliance with a Heart Healthy lifestyle after discharge from a cardiac outpatient rehabilitation program. Patients will be randomized into one of two groups: usual care (control: UC) or Movn mobile application (intervention: MVN). This study will improve and strengthen data collection from this at-risk patient population by recording baseline clinical and psycho social measures while gaining insight into self-reporting of physical activity and frequency between the UC and MVN groups.

Condition or disease	Intervention/treatment	Phase
Cardiac Disease; Pulmonary Disease; Cardiopulmonary Disease	Behavioral: Usual Care; Behavioral: Movn application (MVN)	Not Applicable

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 67 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Double (Participant, Investigator)
• Primary Purpose: Prevention
• Official Title: Empowering Individuals Post-Cardiopulmonary Outpatient Rehabilitation to Continue to Live a Heart Healthy Lifestyle: Utilizing Mobile Health Technology
• Actual Study Start Date: January 2016
• Actual Primary Completion Date: August 31, 2017
• Actual Study Completion Date: March 1, 2018

Arms and Interventions

Arm	Intervention/treatment
Active Comparator: Usual Care (UC)	Behavioral: Usual Care; Discharge packet of Heart Healthy instructions, with self-report health status, quality of life and psychosocial questionnaires, as well as other educational handouts, exit interview to review exercise progress, receive referrals to additional medical services they might need after discharge from the program, with physician.
Active Comparator: Movn application (MVN)	Behavioral: Movn application (MVN); Intervention participants will receive the same discharge packet as the UC group along with their exit interview and will receive the following: Participant individualized Heart Healthy instructions for post-cardiac rehabilitation will be integrated into the MVN application including daily medication reminders, physical activity prompts, educational materials, and patient-reported outcome assessment of behavior and psychosocial status.; Text messages will be used on an ad hoc basis to provide positive feedback to the participant; two-way messaging between the participant and the research coordinator will be available to provide opportunities to answer specific questions.

Outcome Measures

Primary Outcome Measures :

1. Difference in rate of exercise compliance in standard post cardiac rehabilitation compared to the increased rates of exercise compliance observed with the help of smartphone applications [ Time Frame: 6 Months ]
2. Difference in Diastolic blood pressure in subjects who have received andard post cardiac rehabilitation compared to of exercise compliance observed with the help of smartphone applications [ Time Frame: 6 Months ]

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 75 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Current participants in The Joan and Joel Smilow Cardiac Rehabilitation and Prevention Center (JJCRPC) of Rusk Rehabilitation Patient within two weeks of completing outpatient cardiac rehabilitation
• Clinically stable: moderate to low risk strata by standardized clinical assessment
• Clinically stable: moderate to low risk strata by standardized clinical assessment
• no infections
• no unstable arrhythmias, aortic stenosis, thrombophlebitis, dissecting aneurysm or symptomatic anemia
• controlled blood pressure-resting diastolic <100 mmHg, systolic <180mmHg
• no uncompensated heart failure NYHA Class 3-4
• stable angina (no chest pain for month)
• no 2nd or 3rd degree heart block
• no uncontrolled high grade exercise induced ventricular ectopy-hemodynamically stable
• Own an iPhone (version 3 or above), an iPad, or an iPod touch (version 4 or higher) or Android phone or tablet
• Ability to use and comfortable with using mobile health technology to monitor physical and psychosocial health
• Is comfortable using mobile applications
• English language fluency
• Ability to provide informed consent

Exclusion Criteria:

• Patients who do not fulfill all inclusion criteria stated above.

Contacts and Locations

Locations

United States, New York

New York University School of Medicine

New York, New York, United States, 10016

Sponsors and Collaborators

NYU Langone Health

Investigators

• Principal Investigator: Tamara Bushnik, MD; New York University Medical School

More Information

• Responsible Party: NYU Langone Health
• ClinicalTrials.gov Identifier: NCT02671669
• Other Study ID Numbers: 14-01809
• First Posted: February 2, 2016
• Last Update Posted: May 22, 2020
• Last Verified: May 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Heart Diseases; Pulmonary Heart Disease; Cardiovascular Diseases